BioCatalyst

Belzutifan, Cabozantinib — catalyst calendar

1 verified catalyst event(s) referencing Belzutifan, Cabozantinib, each linked to its official source. Verified as of 2026-10-23.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02-26
in 4mo
ESTIMATED
 READOUT
A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Pati
Phase 2 · Renal Cell Carcinoma (RCC), Clear Cell Renal Cell Carcinoma (ccRCC)
 Peloton Therapeutics, Inc., a subs Belzutifan, Cabozantinib ClinicalTrials.gov ↗
✓ Source-checked 2026-10-23
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.